Literature DB >> 7235630

Vascular adrenergic receptor responses in skeletal muscle in myotonic dystrophy.

F Mechler, F L Mastaglia.   

Abstract

The pharmacological responses of vascular adrenergic receptors to intravenously administered epinephrine, phentolamine, and propranolol were assessed by measuring muscle blood flow (MBF) changes in the tibialis anterior muscle using the xenon 133 clearance technique and were compared in 8 normal subjects and 11 patients with myotonic dystrophy. In cases with advanced involvement of the muscle, the resting MBF was reduced and was not significantly altered by epinephrine before or after alpha- or beta-receptor blockade. In patients in whom the tibialis anterior muscle was normal or only minimally affected clinically, a paradoxical reduction in the epinephrine-induced increase in MBF was found after alpha blockade by phentolamine, and the epinephrine-induced MBF increase was not completely blocked by propranolol as in the normal subjects. These findings point to functional alteration in the properties of vascular adrenergic receptors in muscle in myotonic dystrophy. While this may be another manifestation of a widespread cell membrane defect in the disease, the possibility that the changes are secondary to the myotonic state cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7235630     DOI: 10.1002/ana.410090209

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  6 in total

Review 1.  Ionic transporting systems of skeletal muscle in relation with innervation and their involvement in myotonic diseases.

Authors:  J F Renaud
Journal:  Neurochem Res       Date:  1991-06       Impact factor: 3.996

2.  Lymphocyte capping in myotonic dystrophy.

Authors:  G L Walker; U Karagol; E C Mathieson; R J Lane; F L Mastaglia
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-01       Impact factor: 10.154

3.  Heart rate variability declines with increasing age and CTG repeat length in patients with myotonic dystrophy type 1.

Authors:  Bradley A Hardin; Miriam R Lowe; Deepak Bhakta; William J Groh
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-07       Impact factor: 1.468

4.  Deficiency of Na+/K(+)-ATPase and sarcoplasmic reticulum Ca(2+)-ATPase in skeletal muscle and cultured muscle cells of myotonic dystrophy patients.

Authors:  A A Benders; J A Timmermans; A Oosterhof; H J Ter Laak; T H van Kuppevelt; R A Wevers; J H Veerkamp
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

5.  Assessment of autonomic function in myotonic dystrophy.

Authors:  J C den Heijer; J G van Dijk; W L Bollen; J E Bos; A R Wintzen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-06       Impact factor: 10.154

6.  Autonomic nervous system function in myotonic dystrophy.

Authors:  G Pierangeli; A Lugaresi; M Contin; P Martinelli; P Montagna; P Parchi; A Verlicchi; P Cortelli
Journal:  Ital J Neurol Sci       Date:  1992-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.